HOLX wasting no time rolling out the Lorad System:
BEDFORD, Mass., Nov. 6 /PRNewswire/ -- Hologic, Inc. (Nasdaq:
HOLX - news), today announced completion of an agreement between its
Lorad division and Ethicon Endo-Surgery for non-exclusive distribution
rights in the United States to Ethicon's minimally invasive breast biopsy
device, the Mammotome ST. Under the terms of the agreement, Hologic
may offer the Mammotome ST for purchase with Lorad's MultiCare(TM)
and StereoLoc® II stereotactic breast biopsy systems. Lorad is a leading
provider of state-of-the-art mammography and breast biopsy systems.
According to Jack W. Cumming, CEO and President of Hologic, ``We are
pleased to enter into this agreement with Ethicon Endo-Surgery. The
Mammotome ST is fully compatible with Lorad's breast biopsy systems,
the MultiCare and StereoLoc II, which use advanced digital imaging to
pinpoint the precise location of areas for biopsy, ensuring the accuracy and
efficiency of the procedure. We believe the capability to offer highly
accurate breast biopsies with both our upright and prone stereotactic breast
biopsy systems can be significantly enhanced through the use of this
device.''
The Mammotome ST is a reliable diagnostic alternative to open surgical
biopsy and can obtain multiple tissue samples through a single, small
incision in the skin, under local anesthesia. Open surgical biopsy removes a
larger section of tissue through a 1 - 3 inch incision, often under general
anesthesia.
Commenting on the agreement, Pete Kershaw, Vice President & General
Manager of Lorad said, ``In fulfilling Lorad's commitment to the improvement of women's health, we
continuously seek adjunctive technologies to enhance our existing product offerings. Use of the
Mammotome ST with our breast biopsy systems provides practitioners a safe, innovative alternative to
open surgical biopsy. We believe the agreement with Ethicon Endo-Surgery will be mutually beneficial
and we are pleased to have the opportunity to offer our customers this complementary technology.'' |
